NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 73 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,963,078 | -18.2% | 937,683 | +0.2% | 0.00% | – |
Q2 2023 | $3,622,935 | +83.1% | 936,159 | +31.0% | 0.00% | – |
Q1 2023 | $1,979,176 | -21.7% | 714,504 | -49.1% | 0.00% | – |
Q4 2022 | $2,527,934 | +82.8% | 1,404,408 | +115.3% | 0.00% | – |
Q3 2022 | $1,383,000 | -11.4% | 652,325 | +12.4% | 0.00% | – |
Q2 2022 | $1,561,000 | +93.4% | 580,183 | +212.0% | 0.00% | – |
Q1 2022 | $807,000 | -12.1% | 185,955 | +4.9% | 0.00% | – |
Q4 2021 | $918,000 | -5.2% | 177,200 | +12.4% | 0.00% | – |
Q3 2021 | $968,000 | – | 157,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |